 |
 |

Are -Blockers Useful to Protect High-Risk Patients Scheduled for Open Cholecystectomy?Reply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In reply
Our study identified perioperative underutilization of -blockers in patients with risk for CAD despite their use having been incorporated in the American College of Physicians (ACP) practice guidelines.1 Beattie et al and Marret and Albaladejo raise the question of benefit of perioperative -blockers in nonhigh-risk patients and refer to 2 analyses by Auerbach and Goldman2 and Stevens et al3 in support of this. We agree that the benefit of perioperative -blockers in nonhigh-risk patients is less clear compared with high-risk patients undergoing major surgical procedures. Clearly, more work needs to be done in this area. However, our study was intended to assess physicians concordance with practice guidelines without providing an assessment of the guidelines themselves. In fact, in our article we speculated that based on the available evidence physicians might perceive only a small benefit of -blockade, which could have contributed to the limited -blocker use in our . . . [Full Text of this Article] AUTHOR INFORMATION
Shahid Ahmed, MD;
Anita K. Siddiqui, MD;
Henri Delbeau, MD;
Joseph Mattana, MD
RELATED ARTICLES
Are -Blockers Useful to Protect High-Risk Patients Scheduled for Open Cholecystectomy?
Emmanuel Marret and Pierre Albaladejo
Arch Intern Med. 2005;165(3):348.
EXTRACT
| FULL TEXT
Lack of Physician Concordance With Guidelines on the Perioperative Use of -Blockers
Anita K. Siddiqui, Shahid Ahmed, Henri Delbeau, David Conner, and Joseph Mattana
Arch Intern Med. 2004;164(6):664-667.
ABSTRACT
| FULL TEXT
-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review
Andrew D. Auerbach and Lee Goldman
JAMA. 2002;287(11):1435-1444.
ABSTRACT
| FULL TEXT
|